Entrada Therapeutics
TRDA
#7234
Rank
S$0.52 B
Marketcap
$13.94
Share price
-2.98%
Change (1 day)
-18.23%
Change (1 year)

Revenue for Entrada Therapeutics (TRDA)

Revenue in 2024 (TTM): S$0.28 Billion

According to Entrada Therapeutics's latest financial reports the company's current revenue (TTM ) is S$0.28 Billion. an increase over the revenue in the year 2023 that were of S$0.17 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Entrada Therapeutics from 2021 to 2024

Annual revenue

Year Revenue Change
2024 S$0.28 B68.15%
2023 S$0.17 B
2022 N/A
2021 N/A